Ben-Porat, Tair http://orcid.org/0000-0001-5860-4972
Yousefi, Reyhaneh
Stojanovic, Jovana
Boucher, Vincent Gosselin
Fortin, Annabelle
Lavoie, Kim
Bacon, Simon L. http://orcid.org/0000-0001-7075-0358
Article History
Received: 7 December 2023
Revised: 20 February 2024
Accepted: 26 February 2024
First Online: 8 March 2024
Competing interests
: TBP, RY, JS, VGB, and AF have nothing to disclose. Dr. Lavoie has served on the advisory board for Schering-Plough, Takeda, AbbVie, Almirall, Janssen, GSK, Astellas, Novartis, Boehringer Ingelheim (BI), and Sojecci Inc. and received sponsorship for investigator-generated research grants from GSK and AbbVie; speaker fees from GSK, Astra-Zeneca, X-Facto, Astellas, Novartis, BI, Takeda, Janssen, AbbVie, Merck, Bayer, Pfizer, Schering-Plough, Mundipharma, and Air Liquide; and support for educational materials from Merck, none of which are related to the current article. Dr. Bacon has received consultancy fees from Respiplus and Merck for the development of behavior change continuing education modules and speaker fees from Respiplus, Novartis, and Janssen and has served on advisory boards for Bayer, Sanofi, and Sojecci Inc., none of which are related to the current article.